SEC Form 4 · accession 0001246360-16-005034
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew W Towse
Officer — SVP and Chief Financial Office
Period of report
Mar 9, 2016
Accepted (ET)
Mar 10, 2016 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.58 | Mar 9, 2016 | A | 89,386 | A | Apr 9, 2016 | Mar 8, 2026 | Common Stock | 89,386 | 89,386 | D |
Explanation of responses
- F1The stock option becomes exercisable in 48 equal monthly installments beginning April 9, 2016.